07/25/2024 3:31 PM | Kiniksa Pharmaceuticals (Issuer) Paolini John F. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/25/2024 3:32 PM | Kiniksa Pharmaceuticals (Issuer) Ragosa Mark (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/25/2024 3:33 PM | Kiniksa Pharmaceuticals (Issuer) Patel Sanj K (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/25/2024 3:10 PM | Kiniksa Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
07/23/2024 6:54 AM | Kiniksa Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/04/2024 11:15 PM | Kiniksa Pharmaceuticals (Filer)
| Form EFFECT | |
07/04/2024 11:15 PM | Kiniksa Pharmaceuticals (Filer)
| Form EFFECT | |
|
06/30/2024 11:15 PM | Kiniksa Pharmaceuticals (Filer)
| Form EFFECT | |
06/28/2024 4:29 PM | Kiniksa Pharmaceuticals (Filer)
| Form S-3 Registration statement under Securities Act of 1933 | |
06/28/2024 4:30 PM | Kiniksa Pharmaceuticals (Filer)
| Form 15-15D | |
06/28/2024 4:22 PM | Kiniksa Pharmaceuticals (Filer)
| Form POS AM | |
06/28/2024 4:22 PM | Kiniksa Pharmaceuticals (Filer)
| Form S-8 POS | |
06/28/2024 4:23 PM | Kiniksa Pharmaceuticals (Filer)
| Form S-8 POS | |
06/28/2024 4:23 PM | Kiniksa Pharmaceuticals (Filer)
| Form S-8 POS | |
06/28/2024 4:24 PM | Kiniksa Pharmaceuticals (Filer)
| Form S-8 POS | |
06/28/2024 4:24 PM | Kiniksa Pharmaceuticals (Filer)
| Form S-8 POS | |
06/28/2024 4:25 PM | Kiniksa Pharmaceuticals (Filer)
| Form S-8 POS | |
06/27/2024 8:34 PM | Kiniksa Pharmaceuticals (Filer)
| Form POS AM | |
06/25/2024 3:30 PM | Kiniksa Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/14/2024 3:27 PM | Kiniksa Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/07/2024 3:35 PM | Kiniksa Pharmaceuticals (Issuer) Quart Barry D (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/07/2024 3:36 PM | Kiniksa Pharmaceuticals (Issuer) Popovits Kimberly J (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/07/2024 3:37 PM | Kiniksa Pharmaceuticals (Issuer) McCain Tracey L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/07/2024 3:39 PM | Kiniksa Pharmaceuticals (Issuer) Malley Thomas (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/07/2024 3:40 PM | Kiniksa Pharmaceuticals (Issuer) Levy Richard S (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/07/2024 3:41 PM | Cole G Bradley (Reporting) Kiniksa Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/05/2024 3:27 PM | Kiniksa Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/29/2024 4:19 PM | Kiniksa Pharmaceuticals (Filer)
| Form DEFA14A | |
05/07/2024 3:46 PM | Kiniksa Pharmaceuticals (Issuer) Levy Richard S (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/30/2024 3:35 PM | Kiniksa Pharmaceuticals (Issuer) Ragosa Mark (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/23/2024 3:36 PM | Kiniksa Pharmaceuticals (Filer)
| Form DEF 14A | |
04/23/2024 3:41 PM | Kiniksa Pharmaceuticals (Filer)
| Form ARS | |
04/23/2024 3:43 PM | Kiniksa Pharmaceuticals (Filer)
| Form DEFA14A | |
04/23/2024 3:46 PM | Kiniksa Pharmaceuticals (Filer)
| Form DEFA14A | |
04/23/2024 6:34 AM | Kiniksa Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/10/2024 4:00 PM | Kiniksa Pharmaceuticals (Filer)
| Form PRE 14A | |
04/08/2024 4:20 PM | Kiniksa Pharmaceuticals (Issuer) Ragosa Mark (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/08/2024 4:21 PM | Kiniksa Pharmaceuticals (Issuer) Paolini John F. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/08/2024 4:22 PM | Kiniksa Pharmaceuticals (Issuer) Patel Sanj K (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/08/2024 4:17 PM | Kiniksa Pharmaceuticals (Issuer) Tessari Eben (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/08/2024 4:18 PM | Kiniksa Pharmaceuticals (Issuer) Megna Michael R (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
We just added a $300 account credit to your MarketBeat subscription (Ad) MarketBeat All Access is our complete suite of portfolio monitoring software, research tools, stock screeners, proprietary reports, and more. Upgrade today and get $300 off your 2024-2025 subscription. Free for 30 days.![](https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx?TriggeredCampaignID=8657&Placement=NativeDisplay&Source=NativeDisplay) Start Your Risk-Free Trial Here |
04/08/2024 4:19 PM | Kiniksa Pharmaceuticals (Issuer) Moat Ross (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/05/2024 11:21 AM | BlackRock Inc. (Filed by) Kiniksa Pharmaceuticals (Subject)
| Form SC 13G/A | |
04/03/2024 4:22 PM | Kiniksa Pharmaceuticals (Issuer) Patel Sanj K (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/03/2024 4:23 PM | Kiniksa Pharmaceuticals (Issuer) Tessari Eben (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/03/2024 4:25 PM | Kiniksa Pharmaceuticals (Issuer) Ragosa Mark (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/02/2024 6:32 AM | Kiniksa Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/29/2024 4:00 PM | Kiniksa Pharmaceuticals (Filer)
| Form DEFA14A | |
03/29/2024 6:30 AM | Kiniksa Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/29/2024 6:30 AM | Kiniksa Pharmaceuticals (Filer)
| Form DEFA14A | |
03/11/2024 6:05 PM | Kiniksa Pharmaceuticals (Issuer) Patel Sanj K (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/06/2024 4:37 PM | Kiniksa Pharmaceuticals (Issuer) Patel Sanj K (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/04/2024 5:24 PM | Kiniksa Pharmaceuticals (Subject) Patel Sanj K (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/01/2024 5:26 PM | Kiniksa Pharmaceuticals (Issuer) Megna Michael R (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/01/2024 4:29 PM | Kiniksa Pharmaceuticals (Subject) Tessari Eben (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/28/2024 4:31 PM | Kiniksa Pharmaceuticals (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/28/2024 6:35 AM | Kiniksa Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/14/2024 2:46 PM | Fairmount Funds Management LLC (Filed by) Kiniksa Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/12/2024 5:06 AM | Kiniksa Pharmaceuticals (Subject) Rubric Capital Management LP (Filed by)
| Form SC 13G | |
01/04/2024 6:37 AM | Kiniksa Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/21/2023 3:26 PM | Kiniksa Pharmaceuticals (Issuer) Megna Michael R (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/11/2023 3:20 PM | Kiniksa Pharmaceuticals (Issuer) Paolini John F. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/07/2023 3:46 PM | Kiniksa Pharmaceuticals (Subject) Paolini John F. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/07/2023 3:33 PM | Kiniksa Pharmaceuticals (Issuer) Levy Richard S (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/02/2023 3:15 PM | Kiniksa Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
10/31/2023 6:35 AM | Kiniksa Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/06/2023 3:26 PM | Kiniksa Pharmaceuticals (Issuer) Megna Michael R (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/06/2023 6:03 PM | Kiniksa Pharmaceuticals (Issuer) Paolini John F. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/06/2023 6:04 PM | Kiniksa Pharmaceuticals (Issuer) Tessari Eben (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/06/2023 6:06 PM | Kiniksa Pharmaceuticals (Issuer) Ragosa Mark (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/06/2023 6:06 PM | Kiniksa Pharmaceuticals (Issuer) Patel Sanj K (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/06/2023 6:07 PM | Kiniksa Pharmaceuticals (Issuer) Moat Ross (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/06/2023 6:08 PM | Kiniksa Pharmaceuticals (Issuer) Megna Michael R (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/05/2023 4:26 PM | Kiniksa Pharmaceuticals (Subject) Paolini John F. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/18/2023 3:32 PM | HHLR ADVISORS, LTD. (Filed by) Kiniksa Pharmaceuticals (Subject)
| Form SC 13G/A | |